Acute pancreatitis is a common clinical problem. This case of acute pancreatitis was due to a most uncommon underlying aetiology, a non-functioning neuroendocrine tumour of the pancreas.
EckhauserFECheungPSAlVinikStrodelWELloydRVThompsonNW. Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery1986: 100:978–88.
2.
YeoQWangBHAnthoneGJCameronJL. Surgical experience with pancreatic islet-cell tumors. Arch Surg1993; 128:1143–48.
3.
ModlinIMLewisJJAhlmanHBilchikAJKumarRR. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet1993:176:507–518.
4.
DegenLBerlingerC. The role of octreotide in the treatment of gastroenteropancreatic endocrine tumors. Digestion1999:60Suppl 2:9–14.
5.
di BartolomeoMBajettaEBuzzoniRMarianiLCarnaghiCSommaLZilemboNdi LeoA. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer1996; 77:402–408.
6.
MoertelCCLefkopoulosMLipsitzSHahnRGKlaasenD. Streptozotocin-doxorubicin, streptozotocin-fluorouracil or chlorzotocin in the treatment of advanced islet-cell carcinoma. N Engi J Med1992; 326:519–23.
7.
Eriksson8KLarssonECSkogseidBMLofbergAMLoreflusLEObergKE. Liver embolization of patients with malignant neuroendocrine gastrointestinal tumors. Cancer1998; 83:2293–301.
8.
JansonE TiensuuEriksson8ObergKESkogseidBMOhrvallUNiisson5WestlinJE. Treatment with high dose In-DTPA-D-PHE]-octreotide in patients with neuroendocrine tumors - evaluation of therapeutic and toxic effects. Acta Oncol1999; 38 (3): 373–77.
9.
McCarthyKEWolteringEAEspenanCDCroninMMaloneyTJAnthonyLB.In situ radiotherapy with In-pentetreotide: initial observations and future directions. Cancer J Sci Am1998; 4:94–102.
